GLENDALE, Calif., May 3, 2013 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), an integrated physician-driven healthcare delivery company that puts 'Patients First,' today announced its fiscal year-end results for the three and twelve months ended January 31, 2013.
Financial Highlights for Full Fiscal Year 2013 Compared to Full Fiscal Year 2012:
Financial Highlights for Three Months Ended January 31, 2013 Compared to Three Months Ended January 31, 2012:
As of January 31, 2013, the Company had $1.18 million in cash and cash equivalents, $1.58 million in accounts receivable and total stockholders' deficit of approximately $391,000.
Key Operational Highlights for Fiscal Year 2013
Commenting on the yearend results, ApolloMed CEO Warren Hosseinion, M.D. stated, "On reflection, fiscal 2013 was a very rewarding year for us – a year in which we made vital progress on the expansion of our three core business units; saw material growth in the number of hospitals, physicians and patients we now serve; and gained meaningful traction with our market penetration efforts in Southern and Central California. Moreover, we are very proud of our many notable accomplishments in the last year that helped us close fiscal 2013 on a $10+ million revenue run rate, which firmly positions us to deliver yet another record year in 2014. Practicing strict expense discipline and aggressively ramping sales are among are chief priorities in the current fiscal year and are goals that we believe we are well poised to achieve."
For more details on ApolloMed's fiscal 2013 year-end results, please refer to the Company's 10-K filed with the U.S. Securities Exchange Commission and accessible at www.sec.gov.
FINANCIAL CHARTS TO FOLLOW APOLLO MEDICAL HOLDINGS, INC.CONSOLIDATED BALANCE SHEETSJanuary 31,
2012CURRENT ASSETSCash and cash equivalents
4,361Accounts receivable, net
2,140Due from affiliates
45,601Deferred financing costs, current
37,500Total current assets
1,249,224Deferred financing costs, non-current
-Property and equipment, net
1,364,048LIABILITIES AND STOCKHOLDERS' DEFICITCURRENT LIABILITIES:Accounts payable and accrued liabilities
-Convertible notes payable, net
90,000Due to officers
12,400Total current liabilities
1,515,268Convertible notes payable, net
1,785,268STOCKHOLDERS' DEFICITPreferred stock, par value $0.001 ;
5,000,000 shares authorized; none issued
-Common Stock, par value $0.001; 100,000,000 shares authorized, 34,843,441 and 29,335,774 shares issued and outstanding as of January 31, 2013 and 2012, respectively
238,101Total stockholders' deficit
(421,220)TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
$ 1,364,048 APOLLO MEDICAL HOLDINGS, INC.CONSOLIDATED STATEMENTS OF OPERATIONSYears ended January 31,20132012NET REVENUES
5,110,806COST OF SERVICES
978,407Operating expenses:General and administrative
12,589Total operating expenses
1,391,742LOSS FROM OPERATIONS
(413,335)Other income (expense)Loss on change in fair value of derivative liabilities
(304,034)Other (expense) income
2,842Total other expenses
(301,192)LOSS BEFORE INCOME TAXES
(714,527)Provision for Income Tax
(720,346) APOLLO MEDICAL HOLDINGS, INC.CONSOLIDATED STATEMENTS OF OPERATIONSThree Months Ended January 31 ,Year Ended
LOSS FROM OPERATIONS
$(413,335)Depreciation and amortization expense
(400,746)Issuance of shares for service
152,400Non-cash stock option expense
*Use of Non-GAAP Financial Measures
In addition to containing results that are determined in accordance with accounting principles generally accepted in the United States of America (GAAP), this press release also contains non-GAAP financial measures. Adjusted EBITDA, as used in this press release, represents Loss from Operations before depreciation, adjusted for issuance of shares for service, stock option expense, amortization of debt discount and impairment of intangibles and losses on discontinued operations. Adjusted EBITDA is a key indicator used by management to evaluate operating performance. While adjusted EBITDA is not intended to replace any presentation included in the consolidated financial statements under GAAP and should not be considered an alternative to operating performance or an alternative to cash flow as a measure of liquidity, the Company believes this measure is useful to investors in assessing the Company's ongoing operating performance and working capital requirements. This calculation may differ in method of calculation from similarly titled measures used by other companies. A reconciliation of adjusted EBITDA to the nearest comparable GAAP financial measure is included in the financial schedules accompanying this press release. The Non-GAAP financial measures, as well as other information in this press release, should be read in conjunction with the Company's financial statements filed with the Securities and Exchange Commission.
About Apollo Medical Holdings, Inc. (ApolloMed)
Headquartered in Glendale, California and dedicated to putting the 'Patient First,' ApolloMed is a physician-driven integrated healthcare delivery company, fueled by its commitment to provide exceptional multi-disciplinary care in the communities it serves in Southern and Central California. ApolloMed is addressing the healthcare needs of the nation's largest population center by leveraging its integrated healthcare delivery platform through its complementary physician groups: ApolloMed Hospitalists and ApolloMed ACO (Accountable Care Organization). This platform combines hospitalist medicine, critical care medicine, patient care coordination, case management and transition management that enable healthcare organizations to engage in performance payments for utilization efficiency, quality of care objectives and shared accountability arrangements.
ApolloMed strives to improve medical outcomes with high quality, cost efficient care.
For more information, please visit www.apollomed.net.
Forward Looking Statements
This press release may contain forward-looking statements, including information about management's view of Apollo Medical Holdings, Inc. ("the Company") future expectations, plans and prospects. In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this press release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of the Company, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by Apollo Medical Holdings, Inc.
For More Information, PLEASE CONTACT:
Kathy Addison or Dodi Handy
407-585-1080 or via email at AMEH@hanoverelite.com
|SOURCE Apollo Medical Holdings, Inc.|
Copyright©2012 PR Newswire.
All rights reserved